STAT3 drives cancer cell proliferation, survival, invasion, and metastasis, and also has been implicated in chemoresistance; thus, c-Abl/Arg may drive doxorubicin resistance by activating STAT3 [12], [32], [52]. Here, STAT3 is linked to cancer.